Brief: NGM Bio Reports Q4 2020 Financial Results
04/03/2021 22:36
March 4 (Reuters) - NGM Biopharmaceuticals Inc NGM.O :
* QTRLY RELATED PARTY REVENUE $19.8 MILLION VERSUS $31.1
MILLION
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.40
* Q4 EARNINGS PER SHARE VIEW $-0.47, REVENUE VIEW $22.0
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbBxZFt
Further company coverage: NGM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NGM Biopharmaceuticals
See all newsBrief: NGM Biopharmaceuticals Q4 Net Income USD -27.67 Million
Brief: NGM Bio Enters into a Definitive Agreement and Plan of Merger with Certain Affiliates of The Column Group
NGM Biopharmaceuticals Inc expected to post a loss of 39 cents a share - Earnings Preview
Brief: Ngm Biopharmaceuticals Says It Got Written Notice From Nasdaq Informing It Has Regained Compliance With Nasdaq Listing
Brief: NGM Bio Announces New Clinical Data From Ongoing Trial Of Ngm707 In Advanced Solid Tumors